GLP-1 Weight Loss in Anchorage (2026)

Anchorage at a Glance

About GLP-1 Access in Anchorage

Anchorage is the largest city in Alaska, located in Alaska with a population of approximately 291,000. Telehealth is legal in Alaska, and licensed GLP-1 providers can prescribe semaglutide or tirzepatide and ship directly to Anchorage ZIP codes. Prices, formulary availability, and specific provider state coverage vary — confirm with the provider before starting.

Anchorage is the population center of its own metro area, with roughly 398,328 residents across the wider metro — most of the local telehealth demand originates in the city itself.

Alaska's adult obesity rate is approximately 34.0% based on CDC Behavioral Risk Factor Surveillance System data^[2], and state rankings are published in CDC's Adult Obesity Facts^[3]. Alaska ranks #24 of 50 states for adult obesity prevalence — near the national middle — and telehealth gives Anchorage residents a fast, private alternative to scheduling with a local obesity-medicine specialist. Before starting treatment, it's worth understanding what the clinical trials actually showed about GLP-1 side effects.

Alaska Medicaid does not currently cover GLP-1s for weight loss alone (Diabetes only), which is why cash-pay compounded semaglutide or tirzepatide — averaging $229/month — is the realistic path for most Anchorage residents seeking obesity treatment outside a type 2 diabetes diagnosis.

Looking beyond Anchorage? See all GLP-1 providers in Alaska, or read our Alaska Medicaid GLP-1 coverage & prior-authorization guide.

Browse by Medication

Browse all 338 providers with undisclosed coverage on the Alaska page →

In-Person vs Telehealth in Anchorage

Patients in Anchorage have two main paths to GLP-1 treatment: an in-person obesity medicine or bariatric program, or a licensed telehealth provider that ships to Alaska addresses. In-person programs are generally preferable for patients with complex medical needs, those pursuing bariatric surgery, or patients whose insurance covers a brand-name anti-obesity GLP-1 and requires in-person documentation. Telehealth is generally preferable for patients seeking cash-pay compounded semaglutide or tirzepatide from a 503A compounding pharmacy^[5]. Medicaid and commercial insurance coverage of anti-obesity GLP-1s in Alaska varies by plan^[4].

In-person weight-management clinics in Anchorage (41 in our directory)

From the NPI registry, cross-checked against obesity-medicine and bariatric taxonomy codes — mostly endocrinology, diabetes & metabolism.

• Alaska Kidney & Diabetes Association — Endocrinology, Diabetes & Metabolism, 3260 Providence Dr
• J. Ross Tanner, D.O. LLC — Endocrinology, Diabetes & Metabolism, 2841 Debarr Rd
• Janice Koval — Endocrinology, Diabetes & Metabolism, 2841 Debarr Rd Ste 50
• Jeanne Bonar — Endocrinology, Diabetes & Metabolism, 3260 Providence Dr
• Jeffrey D Medland, LLC — Endocrinology, Diabetes & Metabolism, 3260 Providence Dr Ste 523
• Jeffrey Medland — Endocrinology, Diabetes & Metabolism, 2841 Debarr Rd
• Jerry Tanner — Endocrinology, Diabetes & Metabolism, 2841 Debarr Rd Ste 43
• Konrad C Kaltenborn MD — Endocrinology, Diabetes & Metabolism, 4100 Lake Otis Pkwy

Browse all 41 Anchorage clinics in the directory →

Cost of GLP-1 Medications in Anchorage

Brand-name Wegovy in Anchorage typically costs $1,349/month without insurance, while Zepbound runs $1,086/month. Compounded semaglutide through telehealth providers averages $229/month in Alaska, representing savings of more than $13,000 per year. For a full breakdown of every low-cost option, read our cheapest way to get GLP-1s without insurance guide. If you're deciding between the two paths, see our compounded vs. branded GLP-1 decision guide.

Frequently Asked Questions